Kiora Pharmaceuticals, Inc.

This study tested a new drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two rare diseases that cause progressive vision loss. The main goal was to check the treatment's safety and tolerability, while also looking at…